Canada Life’s NeoGenomics NEO Stock Holding History

Canada Life’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$788K	Hold	106,132	–	–	﹤0.01%	1414
2025 Q4	$1.25M	Sell	106,132 -44,008	-29%	-$475K	﹤0.01%	1324
2025 Q3	$1.17M	Buy	150,140 +15,403	+11%	+$108K	﹤0.01%	1400
2025 Q2	$986K	Sell	134,737 -7,816	-5%	-$63.1K	﹤0.01%	1436
2025 Q1	$1.35M	Sell	142,553 -9,243	-6%	-$115K	﹤0.01%	1336
2024 Q4	$2.5M	Sell	151,796 -1,373	-0.9%	-$21.3K	﹤0.01%	1163
2024 Q3	$2.26M	Sell	153,169 -5,827	-4%	-$91.2K	﹤0.01%	1243
2024 Q2	$2.21M	Buy	158,996 +16,187	+11%	+$229K	﹤0.01%	1246
2024 Q1	$2.25M	Buy	142,809 +6,148	+4%	+$94.9K	﹤0.01%	1186
2023 Q4	$2.21M	Sell	136,661 -11,371	-8%	-$186K	﹤0.01%	1204
2023 Q3	$1.82M	Sell	148,032 -4,916	-3%	-$73.1K	﹤0.01%	1267
2023 Q2	$2.46M	Sell	152,948 -6,305	-4%	-$104K	0.01%	1084
2023 Q1	$2.77M	Sell	159,253 -5,167	-3%	-$73.6K	0.01%	1064
2022 Q4	$1.52M	Buy	164,420 +4,243	+3%	+$39.6K	﹤0.01%	1362
2022 Q3	$1.38M	Buy	160,177 +37,181	+30%	+$369K	﹤0.01%	1353
2022 Q2	$1M	Buy	122,996 +16,375	+15%	+$156K	﹤0.01%	1469
2022 Q1	$1.33M	Buy	106,621 +829	+0.8%	+$17.4K	﹤0.01%	1411
2021 Q4	$3.61M	Buy	105,792 +1,388	+1%	+$54.4K	0.01%	876
2021 Q3	$5.07M	Buy	104,404 +3,900	+4%	+$181K	0.01%	724
2021 Q2	$4.54M	Buy	100,504 +337	+0.3%	+$14.9K	0.01%	745
2021 Q1	$4.83M	Sell	100,167 -7,775	-7%	-$405K	0.01%	732
2020 Q4	$5.81M	Sell	107,942 -14,455	-12%	-$653K	0.01%	749
2020 Q3	$4.51M	Sell	122,397 -10,753	-8%	-$400K	0.01%	753
2020 Q2	$4.12M	Sell	133,150 -3,617	-3%	-$100K	0.01%	747
2020 Q1	$3.77M	Buy	136,767 +7,632	+6%	+$229K	0.01%	715
2019 Q4	$3.75M	Buy	+129,135	New	+$3.08M	0.01%	814
2019 Q3	–	Sell	-134,353	Closed	-$2.95M	–	1851
2019 Q2	$2.95M	Buy	134,353 +6,075	+5%	+$133K	0.01%	960
2019 Q1	$2.62M	Buy	128,278 +118,427	+1,202%	+$2.06M	0.01%	902
2018 Q4	$120K	Buy	9,851 +3,451	+54%	+$51.4K	﹤0.01%	2086
2018 Q3	$98K	Hold	6,400	–	–	﹤0.01%	2198
2018 Q2	$84K	Hold	6,400	–	–	﹤0.01%	2246
2018 Q1	$52K	Hold	6,400	–	–	﹤0.01%	2357
2017 Q4	$57K	Hold	6,400	–	–	﹤0.01%	2329
2017 Q3	$71K	Hold	6,400	–	–	﹤0.01%	2242
2017 Q2	$57K	Hold	6,400	–	–	﹤0.01%	2285
2017 Q1	$50K	Hold	6,400	–	–	﹤0.01%	2304
2016 Q4	$55K	Hold	6,400	–	–	﹤0.01%	2299
2016 Q3	$52K	Hold	6,400	–	–	﹤0.01%	2330
2016 Q2	$51K	Buy	+6,400	New	+$51.3K	﹤0.01%	2302

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Canada Life's NEO Position: Q1 2026 in Review

Canada Life held its NeoGenomics (NEO) position steady in Q1 2026 at 106,132 shares worth $788K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Canada Life first reported a position in NEO in Q2 2016 and has held it in 39 quarters since. The position peaked at $5.81M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Canada Life held 106,132 shares of NeoGenomics worth $788K as of Q1 2026.
Canada Life left its NeoGenomics share count unchanged in Q1 2026.
NeoGenomics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1414 holding.
Canada Life first reported a position in NeoGenomics in Q2 2016 and has held it in 39 quarters since.
Canada Life's NeoGenomics position peaked at $5.81M in Q4 2020.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.